Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 17.79
- Piotroski Score 5.00
- Grade Overweight
- Symbol (WST)
- Company West Pharmaceutical Services, Inc.
- Price $321.01
- Changes Percentage (3%)
- Change $9.35
- Day Low $308.46
- Day High $321.17
- Year High $413.70
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
- Last Earnings 10/24/2024
- Ex-Dividend for 5/16 Dividend 11/13/2024
- Dividend Payable 11/20/2024
- Today N/A
- Next Earnings (Estimated) 02/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $250.00
- High Stock Price Target $393.00
- Low Stock Price Target $250.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $7.56
- Trailing P/E Ratio 41.62
- Forward P/E Ratio 41.62
- P/E Growth 41.62
- Net Income $593.40 M
Income Statement
Quarterly
Annual
Latest News of WST
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
Twist Bioscience Corp's 2025 guidance doesn't include MRD growth, indicating uncertainty. Express Genes expects a 50% gross margin by Q4. Minimal exposure to NIH budgets gives a competitive edge. Next...
By Yahoo! Finance | 2 days ago -
When does the next episode of 'Yellowstone' come out? Full Season 5, Part 2 episode schedule
Cole Hauser and Kelly Reilly discuss the return of "Yellowstone" and the iconic scene with wolves. Kevin Costner's character fate revealed in Season 5, Part 2. New episodes air Sundays on Paramount Ne...
By USA Today | 3 days ago -
'Yellowstone' star Wes Bentley admits playing Jamie has been a 'real...
Wes Bentley, from "Yellowstone," discusses the challenges of portraying his character Jamie and how his evil deeds affect him. The hit series follows the Dutton family and has drawn in 17 million view...
By New York Post | 3 days ago
